Corporació Sanitària Parc Taulí

Sabadell, Barcelona 08208

0 studies enrolling now · 1 studies all time

What they study most

End-stage Renal Disease, Hemodiafiltration, Hemodialysis, Prevention of Thromboembolic Events

Studies at this site

• Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis — Completed